Ropes & Gray advised Ginkgo Bioworks on the transaction. Ginkgo Bioworks (NYSE: DNA) announced the acquisition of Patch Biosciences, which has built an AI platform for sequence design that...
Ginkgo Bioworks’ Acquisition of Patch Biosciences
ImmunoGen’s Multi-Target License and Option Agreement with ImmunoBiochem
Ropes & Gray represented ImmunoGen in the deal. ImmunoGen, Inc. announced a multi-target license and option agreement to research novel, first-in-class ADCs with ImmunoBiochem Corporation on the...
Pfizer’s Strategic Collaboration with Flagship Pioneering
Ropes & Gray advised Pfizer on the deal. Pfizer announced a strategic collaboration with Flagship Pioneering to create a new pipeline of innovative medicines. The collaboration...
Advent and Warburg Pincus’ Acquisition of BioPharma Solutions from Baxter
Cleary Gottlieb Steen & Hamilton and Ropes & Gray are serving as legal advisor to Advent and Warburg Pincus, while Sullivan & Cromwell is serving as...
Sanofi’s $2.9 Billion Acquisition of Provention Bio
Ropes & Gray represented Provention Bio, Inc. on the deal. Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced a sales agreement...
HUTCHMED’s License Agreement with Takeda Pharmaceutical
Ropes & Gray represented HUTCHMED on the deal. HUTCHMED (China) Limited and its subsidiary, HUTCHMED Limited announced an exclusive worldwide license agreement with Japan’s largest drugmaker Takeda...
Immunogen’s Research Collaboration with Biosion
Ropes & Gray advised ImmunoGen on the deal. ImmunoGen, a leader in the field of antibody-drug conjugates for cancer treatment, announced a research collaboration with Biosion USA,...
Ginkgo Bioworks and Bayer’s Collaboration to Build Agricultural Biologicals R&D Platform
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, announced the closing a transaction with Bayer for a...
Ginkgo Bioworks’ $83 Million Collaboration With Bayer
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, signed an agreement with Bayer to expand Ginkgo’s platform capabilities...
Ginkgo Bioworks’ Acquisition of Zymergen Inc.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...